Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Adipokines: another link between obesity and hypertension

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Byrd JB, Brook RD . A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension. J Hum Hypertens 2014; 28: 3–9.

    Article  CAS  Google Scholar 

  2. Fonseca-Alaniz MH, Takada J, Alonso-Vale MILima FB . Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J) 2007; 83: S192–S203.

    Article  Google Scholar 

  3. Sowers JR, Whaley-Connell A, Epstein M . Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150: 776–783.

    Article  Google Scholar 

  4. Caprio M, Feve B, Claes A, Viengchareun S, Lombes MZennaro MC . Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 2007; 21: 2185–2194.

    Article  CAS  Google Scholar 

  5. Ehrhart-Bornstein M, Arakelyan K, Krug AW, Scherbaum WABornstein SR . Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res 2004; 30: 865–870.

    Article  CAS  Google Scholar 

  6. Martins LC, Figueiredo VN, Quinaglia T, Boer-Martins L, Yugar-Toledo JC, Martin JF et al. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness. J Hum Hypertens 2011; 25: 532–538.

    Article  CAS  Google Scholar 

  7. Sabbatini AR, Faria AP, Barbaro NR, Gordo WM, Modolo RGP, Pinho C et al. Deregulation of adipokines related to target organ damage on resistant hypertension. J Hum Hypertens, (e-pub ahead of print 28 November 2013 doi:10.1038/jhh.2013.118).

  8. de Faria AP, Demacq C, Figueiredo VN, Moraes CH, Santos RC, Sabbatini AR et al. Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension. Hypertens Res 2013; 36 (12): 1067–1072.

    Article  CAS  Google Scholar 

  9. de Haro Moraes C, Figueiredo VN, de Faria AP, Barbaro NR, Sabbatini AR, Quinaglia T et al. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension. J Hum Hypertens 2013; 27: 225–230.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Moreno.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sabbatini, A., de Faria, A., Modolo, R. et al. Adipokines: another link between obesity and hypertension. J Hum Hypertens 29, 210 (2015). https://doi.org/10.1038/jhh.2014.28

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2014.28

Search

Quick links